Skip to main content
Market Outlook Snapshot Market Dynamics Regional Forecast Country Insights Segment Analysis Competitive Landscape Industry News FAQ
On This Report

Infection Control Market Size & Growth Forecast 2027–2036, By Segments (Type, End-use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Report ID: FBI 3884| Published Date: Jun-2026| Format: PDF, Excel
Market Outlook

Market Size and Growth Outlook

Infection Control Market size was over USD 58.5 billion in 2026 and is likely to grow at a 5.99% CAGR between 2027 and 2036, crossing USD 104.67 billion by 2036. The industry revenue for 2027 is estimated at USD 61.45 billion.

Base Year Value (2026)
USD 58.5 billion
CAGR (2027-2036)
5.99%
Forecast Year Value (2036)
USD 104.67 billion
Historical Data Period
2022-2026
Largest Region
North America
Forecast Period
2027-2036

Get more details on this report

Request Free Sample Report
Snapshot

Infection Control Market Intelligence Snapshot

Regional Market Dynamics

  • North America leads with a 51.20% share, supported by strong hospital infrastructure, strict infection prevention protocols, and continuous demand for sterilization and disinfection across healthcare settings.
  • Asia Pacific is expanding at a 7.68% CAGR, driven by healthcare infrastructure expansion and increasing adoption of standardized hygiene and contamination-control practices in hospitals and labs.

Segment Momentum

  • Consumables lead the market because infection prevention protocols require continuous replenishment of products used in sterilization, disinfection, and contamination control, creating steady recurring demand.
  • Medical Device Companies are the fastest-growing end-use segment as infection control becomes increasingly important for contamination prevention, quality assurance, and regulatory compliance throughout production workflows.

Market Expansion Drivers

  • Increasing incidence of hospital-acquired infections driving demand for advanced sterilization solutions.
  • Government infection prevention guidelines accelerating healthcare investment in disinfection technologies.
  • Rising adoption of UV disinfection and antimicrobial surface technologies improving infection management outcomes.

Leading Market Participants

  • Top companies in the infection control market include STERIS plc (United States), 3M Company (United States), Getinge AB (Sweden), Advanced Sterilization Products (United States), Belimed AG (Switzerland), Ecolab Inc. (United States), MMM Group (Germany), Sterigenics U.S. LLC (United States), Midmark Corporation (United States), W&H Dentalwerk Bürmoos GmbH (Austria).

Forecast Snapshot

Global Market Forecast Snapshot

Market Outlook

  • 2026 Market Size: USD 58.5 billion
  • 2027 Estimated Market Size: USD 61.45 billion.
  • Projected Market Size: USD 104.67 billion by 2036
  • Growth Forecast: 5.99% CAGR (2027-2036)

Regional and Segment Outlook

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Consumables (Type) | Hospitals (End-use)
  • Emerging Opportunity Segment: Services (Type) | Medical Device Companies (End-use)
Market Dynamics

Market Growth Drivers and Industry Trends

Increasing incidence of hospital-acquired infections driving demand for advanced sterilization solutions

The increasing prevalence of hospital-acquired infections is creating greater pressure on healthcare providers to strengthen infection prevention protocols, which will drive the infection control market growth through wider deployment of advanced sterilization and disinfection solutions. Hospitals and other clinical facilities are increasingly prioritizing technologies capable of reducing microbial contamination across surgical instruments, patient-care areas, and medical equipment, particularly where conventional cleaning procedures may not provide consistent protection. This emphasis on minimizing healthcare-associated infection risks is also encouraging investment in more efficient sterilization systems that can support stringent hygiene requirements while fitting into increasingly complex clinical workflows.

Government infection prevention guidelines accelerating healthcare investment in disinfection technologies

Stricter public health requirements and infection prevention guidelines are encouraging healthcare facilities to allocate more resources toward modern disinfection infrastructure, thereby supporting demand across the infection control market. Regulatory emphasis on maintaining hygienic clinical environments is prompting hospitals, laboratories, and long-term care facilities to strengthen routine sanitation procedures and adopt technologies that provide more reliable microbial control. Such guidelines also encourage standardized infection prevention practices across healthcare settings, increasing the need for equipment and systems that can be integrated into established cleaning protocols and monitored as part of broader quality and safety programs.

Rising adoption of UV disinfection and antimicrobial surface technologies improving infection management outcomes

The growing use of UV-based disinfection and antimicrobial surface technologies is reshaping infection prevention strategies by adding complementary methods for controlling pathogens across frequently exposed environments, supporting infection control market growth. UV systems can be deployed in selected clinical spaces and equipment-processing applications, while antimicrobial surfaces help reduce the persistence of microorganisms on high-touch areas between routine cleaning cycles. Their adoption is particularly relevant in environments where maintaining consistent hygiene is challenging, as healthcare providers seek layered infection management approaches that combine conventional disinfection with technology-enabled microbial reduction.

Growth Driver Impact on CAGR Regulatory Influence Geographic Relevance Adoption Rate Impact Timeline
Increasing incidence of hospital-acquired infections driving demand for advanced sterilization solutions 2.00% High North America, Europe High Near Term
Government infection prevention guidelines accelerating healthcare investment in disinfection technologies 1.90% High North America, Asia Pacific High Mid Term
Rising adoption of UV disinfection and antimicrobial surface technologies improving infection management outcomes 1.50% Moderate Europe, Asia Pacific Emerging Mid Term
Custom Research

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
Regional Forecast

Regional Demand Dynamics

Infection Control Market
Largest Region
North America
51.2% Market Share in 2026

North America (Largest Region)

In the infection control market, North America held the largest share of 51.20% in 2026, supported by advanced healthcare infrastructure, established infection prevention practices, and stringent standards governing clinical safety. High awareness of healthcare-associated infection risks encourages healthcare facilities to adopt sophisticated sterilization, disinfection, and monitoring solutions. Ongoing investments in hospital modernization and stronger emphasis on quality of care further sustain regional demand.

Asia Pacific (Fastest-Growing Region)

Asia Pacific is the fastest-growing region, driven by expanding healthcare infrastructure, rising medical service utilization, and increasing awareness of infection prevention. Growing investments in hospitals and healthcare facilities are supporting the adoption of modern sterilization and disinfection technologies, while strengthening healthcare standards are encouraging providers to improve infection control capabilities.

Parameter North America Asia Pacific Europe Latin America MEA
Innovation Hub i Scale Nascent Developing Advanced
Cost-Sensitive Region i Scale Low Medium High
Regulatory Environment i Scale Restrictive Neutral Supportive
Demand Drivers i Scale Weak Moderate Strong
Development Stage i Scale Emerging Developing Developed
Adoption Rate i Scale Low Medium High
New Entrants / Startups i Scale Sparse Moderate Dense
Macro Indicators i Scale Weak Stable Strong
Country Insights

Key Country Insights

Germany 🇩🇪

Hospital Hygiene Modernization

Germany prioritizes infection control through hospital hygiene upgrades, validated sterilization practices, and stricter quality assurance standards. The country's healthcare institutions increasingly adopt digital monitoring and standardized infection prevention solutions to improve operational consistency.

France 🇫🇷

Regulatory Compliance Focus

France supports the infection control market through rigorous healthcare hygiene standards and continuous investment in hospital safety initiatives. Healthcare organizations prioritize validated sterilization processes and infection surveillance tools that reinforce regulatory compliance and clinical quality.

Italy 🇮🇹

Healthcare Facility Upgrades

Italy continues expanding the infection control market by modernizing healthcare infrastructure and improving sterilization workflows. Italian hospitals increasingly adopt standardized cleaning protocols and advanced infection prevention equipment to enhance patient care environments.

Japan 🇯🇵

Precision Prevention Focus

Japan advances the infection control market by emphasizing high-quality sterilization procedures and disciplined hygiene management across healthcare facilities. Aging demographics encourage broader adoption of efficient infection prevention technologies that support continuous clinical care.

South Korea 🇰🇷

Smart Healthcare Integration

South Korea strengthens the infection control market through digitally enabled hospital operations and advanced sanitation technologies. Healthcare providers increasingly combine automated monitoring, rapid diagnostics, and modern disinfection systems to improve infection prevention efficiency.

United States 🇺🇸

Advanced Clinical Adoption

The U.S. infection control market emphasizes integrated prevention strategies across hospitals, outpatient facilities, and long-term care settings. Healthcare providers continue investing in automated disinfection technologies, surveillance systems, and compliance-focused infection prevention protocols to strengthen patient safety.

Segment Analysis

Segment Leadership and Growth Trends

Infection Control Market Share (%), by Type, 2026

Consumables
Equipment
Services

Go beyond the chart, access full insights & data tables

Request Free Sample Report

Type Segment Analysis: Consumables (Largest Segment) vs Services (Fastest-Growing Segment)

Consumables segment accounted for the largest share of the infection control market in 2026, supported by the recurring need for disinfectants, sterilization products, protective supplies, and other infection prevention materials across healthcare environments. These products are continuously required to maintain hygiene standards, reduce the transmission of pathogens, and support safe clinical procedures. Increasing infection prevention awareness, stringent hygiene practices, and the ongoing need for routine sterilization and disinfection are sustaining consistent demand for infection control consumables.

Services are expected to be the fastest-growing segment as healthcare facilities increasingly seek specialized expertise for infection prevention, sterilization management, environmental hygiene, and compliance-related activities. Outsourced services can help organizations strengthen infection control practices while addressing operational complexity and specialized workforce requirements. Growing emphasis on comprehensive infection prevention programs, continuous monitoring, and adherence to evolving healthcare safety standards is encouraging greater reliance on professional infection control services.

End-use Segment Analysis: Hospitals (Largest Segment) vs Medical Device Companies (Fastest-Growing Segment)

Hospitals segment maintained the largest share of the infection control market in 2026, owing to the high volume of clinical procedures and the extensive infection prevention requirements associated with inpatient and surgical care. Hospitals require comprehensive sterilization, disinfection, environmental cleaning, and protective measures across multiple departments to minimize healthcare-associated infection risks. Increasing focus on patient safety, regulatory compliance, and effective infection prevention protocols continues to make hospitals a major source of demand for infection control products and services.

Medical device companies represent the fastest-growing end-use segment as manufacturers place greater emphasis on maintaining stringent contamination control throughout device production and handling. Effective sterilization and hygienic manufacturing processes are essential for ensuring product safety and meeting quality requirements for medical devices. Growing complexity in device manufacturing, heightened attention to product quality, and increasing focus on contamination prevention across production environments are supporting stronger adoption of infection control solutions within this segment.

Segment Sub-Segment Largest Segment Fastest Growing
Type Equipment, Services, Consumables Consumables Services
End-use Hospitals, Medical Device Companies, Clinical Laboratories, Pharmaceutical Laboratories, Others Hospitals Medical Device Companies
Read our Research Approach →
Competitive Landscape

Competitive Landscape and Market Positioning

Leading companies in the infection control market:

1. STERIS plc (United States)

2. 3M Company (United States)

3. Getinge AB (Sweden)

4. Advanced Sterilization Products (United States)

5. Belimed AG (Switzerland)

6. Ecolab Inc. (United States)

7. MMM Group (Germany)

8. Sterigenics U.S. LLC (United States)

9. Midmark Corporation (United States)

10. W&H Dentalwerk Bürmoos GmbH (Austria)

The infection control market is undergoing rapid development as healthcare providers seek advanced sterilization technologies and environmentally sustainable disinfection solutions. Companies are introducing integrated infection prevention systems that improve operational efficiency while meeting evolving healthcare safety regulations. Within the infection control market, rising investment in automated cleaning technologies and antimicrobial innovations is strengthening competitive differentiation.

Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
STERIS plc (United States)
3M Company (United States)
Getinge AB (Sweden)
Advanced Sterilization Products (United States)
Belimed AG (Switzerland)
Ecolab Inc. (United States)
MMM Group (Germany)
Sterigenics U.S. LLC (United States)
Midmark Corporation (United States)
W&H Dentalwerk Bürmoos GmbH (Austria).
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Industry News

Industry Development/News

Company Name Date Key Development
Seegene May-26 Seegene commercialized a novel PCR-based molecular diagnostic assay in Europe specifically designed to identify multidrug-resistant organisms. This technology integration advances early detection workflows for resistant pathogens, allowing acute care hospitals to mitigate horizontal transmission risks and strengthen targeted containment protocols.
Apollomedics Hospitals May-26 Apollomedics Hospitals integrated the MISSO robotic system to execute 500 robotic knee surgeries, utilizing minimally invasive parameters to optimize perioperative infection control. The adoption highlights a broader operational shift toward robotic platforms that inherently lower surgical site contamination risks compared to traditional open procedures.
Midmark Corporation Jul-24 Midmark Corporation commercialized its next-generation M11 and M9 steam sterilizers, introducing integrated compliance documentation capabilities and optimized instrument processing efficiencies. This product launch directly addresses hospital demands for standardized, data-verifiable infection control workflows and enhanced hardware durability.
Novant Health Thomasville Medical Center Jul-24 Novant Health deployed the SwipeSense digital monitoring platform to automate hand hygiene compliance tracking, raising facility adherence rates from 53% to 84%. The initiative demonstrates the growing commercial scalability and operational impact of IoT-driven behavioral tracking systems in reducing healthcare-associated infections.
Getinge Mar-23 Getinge acquired Ultra Clean Systems Inc. to integrate specialized ultrasonic cleaning technologies into its surgical instrument processing portfolio. The transaction directly enhances Getinge's capability to address sterilization demands for complex and robotic surgery tools, strengthening its competitive positioning in high-precision hospital infection control markets.
W&H Dentalwerk Jan-23 W&H Dentalwerk launched the Lexa Plus sterilizer, a pre-vacuum Class B sterilizer custom-engineered for the North American dental and medical markets. The strategic introduction expands the company's regional footprint in medical device reprocessing and satisfies regional healthcare facility compliance requirements.
Report Customization

Customize Your Report

Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.

1 Custom Segments 2 Custom TOC 3 Related Reports

Infection Control Market — Custom Segments

Segment Sub-Segment
Infection Risk Category Critical, Semi-Critical, Non-Critical
Sterilization Method Steam Sterilization, Low-Temperature Sterilization, Dry Heat Sterilization, Chemical Sterilization, Radiation Sterilization
Procurement Model Direct Procurement, Group Purchasing Organizations, Distributor-Mediated Procurement, Outsourced Infection Control Services

Infection Control Market — Custom TOC

Custom Chapter Custom Details
Healthcare-Associated Infection Prevention Strategy Assessment
  • Infection Prevention Priorities Across Healthcare Settings
  • High-Risk Infection Control Practices and Intervention Areas
  • Hospital Prevention Program Development
  • Technology-Enabled Prevention Opportunities
  • Implementation Priorities Across Care Environments
Hospital Infection Prevention Investment Benchmarking
  • Infection Control Investment Priorities Across Hospitals
  • Spending Allocation Across Prevention Programs and Technologies
  • Infrastructure and Equipment Upgrade Requirements
  • Investment Drivers and Institutional Readiness
Outbreak Preparedness and Response Capability Analysis
  • Healthcare Outbreak Preparedness Frameworks
  • Detection, Containment and Response Capabilities
  • Surge Capacity and Resource Coordination
  • Preparedness Gaps Across Healthcare Systems
  • Technology and Process Priorities for Response Improvement

Need a different cut of the data?

Request Custom Research
Frequently Asked Questions

How big is the infection control market?

In 2027 the market for infection control is worth approximately USD 61.45 billion.

What is the expected industry size of infection control by 2036?

Infection Control Market size was over USD 58.5 billion in 2026 and is likely to grow at a 5.99% CAGR between 2027 and 2036, crossing USD 104.67 billion by 2036.

How are hospital-acquired infections influencing investment priorities in the infection control market?

Rising infection rates are driving healthcare facilities to invest in advanced sterilization systems, monitoring tools, and validated workflows. Procurement increasingly prioritizes consistency, traceability, and compatibility with modern medical devices over routine equipment replacement.

How are regulatory guidelines and emerging disinfection technologies shaping the infection control market?

Infection prevention guidelines encourage investment in compliant disinfection infrastructure, while UV disinfection and antimicrobial surface technologies strengthen integrated infection management by improving environmental protection with greater operational consistency.

Why do Consumables represent the largest segment in the infection control market?

Consumables lead the market because infection prevention protocols require continuous replenishment of products used in sterilization, disinfection, and contamination control, creating steady recurring demand.

Which end-use segment is growing fastest in the infection control market?

Medical Device Companies are the fastest-growing end-use segment as infection control becomes increasingly important for contamination prevention, quality assurance, and regulatory compliance throughout production workflows.

Why does North America dominate the infection control market?

North America leads with a 51.20% share, supported by strong hospital infrastructure, strict infection prevention protocols, and continuous demand for sterilization and disinfection across healthcare settings.

What is driving Asia Pacific’s fastest growth in infection control demand?

Asia Pacific is expanding at a 7.68% CAGR, driven by healthcare infrastructure expansion and increasing adoption of standardized hygiene and contamination-control practices in hospitals and labs.

Who are the major participants shaping the infection control landscape?

Top companies in the infection control market include STERIS plc (United States), 3M Company (United States), Getinge AB (Sweden), Advanced Sterilization Products (United States), Belimed AG (Switzerland), Ecolab Inc. (United States), MMM Group (Germany), Sterigenics U.S. LLC (United States), Midmark Corporation (United States), W&H Dentalwerk Bürmoos GmbH (Austria).
Testimonials

Our Clients

"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."

Project Manager
Siemens Healthcare

"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."

Research and Development (R&D) Manager
GC Biopharma

"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."

Quality Assurance Manager
Medtronic
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL

Research Team Overview

♢
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team

10+
Industry Verticals
100+
Countries Analyzed
5–7
Days Standard
Delivery
12k+
Research Reports
Published
On-
Demand
Customized Research
Available
6
Months Analyst
Support
PDF + XLS
Report Deliverables

Trust & Compliance

☷D&B D-U-N-S
♢GDPR & CCPA Compliant
♙ISO 9001 Certified (ISO 9001:2015)
♙SSL Encryption
▭Secure Payments
✓Confidential Handling

Research Domains

10 coverage areas
Medical Devices & Equipment Diagnostic Imaging Clinical Diagnostics Digital Health & Telemedicine Patient Monitoring Systems Surgical & Minimally Invasive Technologies Healthcare IT & Data Systems Biotechnology & Life Sciences Pharmaceutical Technologies Healthcare Delivery & Services

Research Intelligence

Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts

Research Workflow & Quality Assurance

📥
01

Data Collection

Verified information gathered through primary and secondary research.

🔍
02

Data Triangulation

Cross-validation using multiple independent data sources.

📈
03

Forecast Modelling

Market estimates developed using historical trends and analytical models.

👨‍💼
04

Analyst Validation

Findings reviewed by domain experts for accuracy and consistency.

📝
05

Editorial & Quality Review

Final editorial, quality, and compliance checks before publication.

✅
06

Final Publication

Released after successful completion of the internal review process.

Report Coverage

📊 Market Assessment

  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics

🏢 Competitive Intelligence

  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies

🔍 Strategic Analysis

  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis

🚀 Future Outlook

  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook

Have a question about this report or need a custom scope?

Request Customization
License

Select License Type

Single User
US$ 4,250
Buy Now
Corporate User
US$ 6,150
Buy Now

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →